Suppr超能文献

视频透视评估抗精神病药物治疗的痴呆患者的口咽吞咽困难的病理生理学。

Pathophysiology of Oropharyngeal Dysphagia Assessed by Videofluoroscopy in Patients with Dementia Taking Antipsychotics.

机构信息

Pharmacy Department, Hospital de Mataró, Mataró, Spain.

Gastrointestinal Physiology Laboratory, Hospital de Mataró, Universitat Autónoma de Barcelona, Mataró, Spain; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

J Am Med Dir Assoc. 2018 Sep;19(9):812.e1-812.e10. doi: 10.1016/j.jamda.2018.04.016.

Abstract

OBJECTIVES

The objective of this study was to assess the pathophysiology of oropharyngeal dysphagia (OD) in patients with dementia, specifically in those taking antipsychotics (APs).

DESIGN

A cross-sectional study was performed from January 2011 to May 2017 in a general hospital.

SETTING AND PARTICIPANTS

We included 114 patients with dementia, of which 39 (34.2%) were taking APs (82.5 ± 7.8 years, Barthel Index 52.28 ± 30.42) and 29 patients without dementia (82.4 ± 6.7 years, Barthel Index 77.71 ± 24.7) and OD confirmed by a videofluoroscopy.

MEASURES

Demographical and clinical factors as well as swallowing function of patients with dementia with OD were compared with older patients without dementia with OD. We also compared patients with dementia taking and not taking APs. Impaired efficacy during videofluoroscopy was defined as the presence of oral and/or pharyngeal residue, and impaired safety (unsafe swallow) was defined as aspiration or penetration. Receiver operating characteristic curves were drawn for laryngeal vestibule closure (LVC) time to predict unsafe swallow.

RESULTS

87.7% of patients with dementia presented impaired efficacy of swallow and 74.6% impaired safety [penetration-aspiration scale (PAS) 3.94 ± 1.94]. 86.2% of patients without dementia presented impaired efficacy and 44.8% impaired safety (PAS 2.21 ± 1.92). Time to LVC was significantly delayed in patients with dementia taking APs in comparison with patients without dementia (LVC 0.377 ± 0.093 vs 0.305 ± 0.026, P = .003). In contrast, there were no differences in the PAS and LVC time in patients with dementia taking and not taking APs (PAS 3.96 ± 0.26 vs 3.88 ± 0.22, LVC 0.398 ± 0.117 vs 0.376 ± 0.115, NS). LVC time ≥0.340 seconds predicted unsafe swallow in patients with dementia with an accuracy of 0.71.

CONCLUSIONS/IMPLICATIONS: Patients with dementia presented high prevalence and severity of videofluoroscopy signs of impaired efficacy and safety of swallow and a more severe impairment in airway protection mechanisms (higher PAS and LVC delay). Clinical practice should implement specific protocols to prevent OD and its complications in these patients. AP treatment did not significantly worsen swallowing impairments.

摘要

目的

本研究旨在评估痴呆患者口咽吞咽困难(OD)的病理生理学,特别是服用抗精神病药物(APs)的患者。

设计

这是一项 2011 年 1 月至 2017 年 5 月在一家综合医院进行的横断面研究。

地点和参与者

我们纳入了 114 例痴呆患者,其中 39 例(34.2%)正在服用 APs(82.5±7.8 岁,巴氏指数 52.28±30.42),29 例非痴呆患者(82.4±6.7 岁,巴氏指数 77.71±24.7),且通过视频透视证实存在 OD。

措施

比较了有和无痴呆的伴有 OD 的患者的人口统计学和临床因素以及吞咽功能。我们还比较了服用和未服用 APs 的痴呆患者。视频透视显示疗效受损定义为存在口腔和/或咽部残留,安全性受损(不安全吞咽)定义为误吸或渗透。绘制了声门裂闭合(LVC)时间的受试者工作特征曲线来预测不安全吞咽。

结果

87.7%的痴呆患者吞咽功能受损,74.6%的患者安全性受损[渗透-误吸量表(PAS)3.94±1.94]。86.2%的非痴呆患者吞咽功能受损,44.8%的患者安全性受损(PAS 2.21±1.92)。与无痴呆患者相比,服用 APs 的痴呆患者的 LVC 时间明显延迟(0.377±0.093 与 0.305±0.026,P=0.003)。然而,服用和未服用 APs 的痴呆患者的 PAS 和 LVC 时间无差异(PAS 3.96±0.26 与 3.88±0.22,LVC 0.398±0.117 与 0.376±0.115,NS)。LVC 时间≥0.340 秒可准确预测痴呆患者的不安全吞咽,准确率为 0.71。

结论/意义:痴呆患者存在较高的视频透视显示的吞咽功能障碍和安全性受损的发生率和严重程度,以及气道保护机制的严重受损(更高的 PAS 和 LVC 延迟)。临床实践应制定特定的方案来预防这些患者的 OD 及其并发症。AP 治疗并未显著加重吞咽障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验